Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 431 (LINC00431) is a non-protein coding RNA classified as a long intergenic non-coding RNA (lincRNA), meaning it is a transcript longer than 200 nucleotides that does not overlap with or encode a protein-coding gene[7][9]. Most lincRNAs act in regulating gene expression—by remodeling chromatin, stabilizing RNA, and regulating transcription through diverse mechanisms—which may be tissue- or context-specific[1][3][5]. However, LINC00431 does not currently have any documented function, disease relevance, or therapeutic targeting information available in mainstream biological databases[7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 431 (LINC00431).